dc.creatorBottino, Cassio M. C.
dc.creatorBarcelos-Ferreira, Ricardo
dc.creatorRibeiz, Salma Rose Imanari
dc.date.accessioned2013-11-07T12:03:21Z
dc.date.accessioned2018-07-04T16:15:14Z
dc.date.available2013-11-07T12:03:21Z
dc.date.available2018-07-04T16:15:14Z
dc.date.created2013-11-07T12:03:21Z
dc.date.issued2012
dc.identifierCURRENT PSYCHIATRY REPORTS, NEW YORK, v. 14, n. 4, p. 289-297, AUG, 2012
dc.identifier1523-3812
dc.identifierhttp://www.producao.usp.br/handle/BDPI/43168
dc.identifier10.1007/s11920-012-0281-z
dc.identifierhttp://dx.doi.org/10.1007/s11920-012-0281-z
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1633468
dc.description.abstractDepression is the most frequent mental disorder in older people, often causing emotional distress and reduced quality of life. Despite its clinical significance, depression remains underdiagnosed and inadequately treated in older patients. Regarding prognosis, data suggest that almost 70% of patients, treated long enough and with appropriate doses, recover from an index episode of depression. Antidepressants are efficient for treating depressed outpatients with several comorbid physical diseases as well as hospitalized patients, with selective serotonin reuptake inhibitors being the antidepressants of choice for older patients. Available data can guide pharmacological treatment in both the acute and maintenance stages, but further research is required to guide clinical strategies when remission is not achieved. Approaches for the management of resistance to treatment are summarized, including optimization strategies, drug changes, algorithms, and combined and augmentation pharmacological treatments. Finally, additional therapeutic choices such as electroconvulsive therapy, transcranial magnetic stimulation, and integrated psychotherapy are presented.
dc.languageeng
dc.publisherSPRINGER
dc.publisherNEW YORK
dc.relationCURRENT PSYCHIATRY REPORTS
dc.rightsCopyright SPRINGER
dc.rightsclosedAccess
dc.subjectDEPRESSION
dc.subjectAGING
dc.subjectOLDER ADULTS
dc.subjectCOMORBIDITY
dc.subjectPOLYPHARMACY
dc.subjectANTIDEPRESSANTS
dc.subjectTRICYCLIC ANTIDEPRESSANTS
dc.subjectSELECTIVE SEROTONIN REUPTAKE INHIBITORS
dc.subjectSEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS
dc.subjectMONOAMINE OXIDASE INHIBITORS
dc.subjectADVERSE EFFECTS
dc.subjectTREATMENT
dc.subjectRESISTANCE TO TREATMENT
dc.subjectRECOVERY
dc.subjectELECTROCONVULSIVE THERAPY
dc.subjectTRANSCRANIAL MAGNETIC STIMULATION
dc.subjectINTEGRATED PSYCHOTHERAPY
dc.titleTreatment of Depression in Older Adults
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución